Epidemiology of Pancreatic Cancer in Vojvodina Province in Serbia |
Smiljana, Rajcevic
(Institute of Public Health of Vojvodina)
Mikov, Marica Miladinov (Faculty of Medicine, University of Novi Sad) Petrovic, Vasa (Community Health Center) Jasna, Trifunovic (Faculty of Medicine, University of Novi Sad) Tihomir, Dugandzija (Faculty of Medicine, University of Novi Sad) Milanka, Tatic (Faculty of Medicine, University of Novi Sad) |
1 | Anderson KE, Mack TM, Silverman DT (2006). Cancer Epidemiology and Prevention, New York: Oxford University Press. |
2 | Miladinov-Mikov M, Dugandzija T (2013). Letter to the editor. Arch Oncol, 21, 53 |
3 | Engin H, Bilir C, Ustun H, Gokmen A (2012). ABO blood group and risk of pancreatic cancer in a Turkish population in western blacksea region. Asian Pac J Cancer Prev, 13, 131-3 DOI |
4 | Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al (2013). Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer, 49, 374-1403. |
5 | Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012.Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from:http://globocan.iarc.fr. |
6 | Ghadirian P, Lynch HT, Krewski D (2003). Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev, 27, 87-93. DOI ScienceOn |
7 | Hamilton S.R., Aaltonen L.A., (2000). Pathology and Genetics of Tumours of the Digestive System[e-book], Lyon:IARC Press. |
8 | Howlader N, Noone AM, Krapcho M, et al (2012). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda. |
9 | http://www.ncrc.ac.rs/strane/rakpankreasa.htm |
10 | http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. |
11 | http://seer.cancer.gov/faststats/selections.php?#Output. |
12 | http://eco.iarc.fr/eucan/Cancer.aspx?Cancer=15 |
13 | http://globocan.iarc.fr/old/summary_table_site |
14 | http://www.cancerresearchuk.org/cancer-info/cancerstats/types/pancreas/mortality/ |
15 | http://www-dep.iarc.fr/nordcan/English/StatsFact.asp?cancer=130&country=0 |
16 | http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb2/bb2-chap10.pdf |
17 | Ilic M, Hristina V, Marinkovic J, Kocev N (2013). Pancreatic cancer mortality in Serbia from 1991-2010 - a joinpoint analysis. Croat Med J, 54, 369-75. DOI |
18 | Lowenfels AB, Maisonneuve P (2006). Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol, 20, 197-209 DOI ScienceOn |
19 | Inal A, Ciltas A, Ramazan Y, Berk V, Kos T, Dane F et al, (2012). Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Medical Oncology Multicenter Study. Asian Pac J Cancer Prev, 13, 1841-4 DOI |
20 | Luke C, Price T, Singhal N, Roder D (2009). Pancreatic cancer epidemiology and survival in an Australian population. Asian Pac J Cancer Prev, 10, 369-74 |
21 | Maissonneuveu P, Lowenfeles AB (2010). Epidemiology of pancreatic cancer: An Update. Dig Dis, 28, 645-56 DOI |
22 | Sant M, Allemani C, Santaquilani M, et al (2009). EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer, 45, 931-91 DOI |
23 | Wood HE, Gupta S, Kang JY, et al (2006). Pancreatic Cancer in England and Wales 1975-2000: patterns and trends in incidence, survival and mortality. Aliment Pharmacol Ther, 23, 1205-14 DOI |
![]() |